U.S. indicts Indivior over Suboxone opioid treatment marketing

by on April 11, 2019

The U.S. Justice Department announced on Tuesday the indictment of Indivior Plc and a subsidiary on charges they engaged in an illegal scheme to boost prescriptions of the film version of its opioid addiction treatment Suboxone. (Source: Reuters: Health)

Previous post: